Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment

Alanood S Almurshedi1 Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaCorrespondence[email protected]

Hessah A Aljunaidel2 Drug Regulatory Affairs, Novartis, Riyadh, Saudi Arabia

Bushra Alquadeib1 Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

Basmah N Aldosari1 Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

Iman M Alfagih1 Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

Salma S Almarshidy1 Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

Eram K D Eltahir1 Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

Amany Z Mohamoud1 Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

Your download is now in progress and you may close this window